A Topliss tree analysis of the HIV-protease inhibitory activity of 6-phenyl-4-hydroxy-pyran-2-ones

被引:13
作者
Steinbaugh, BA
Hamilton, HW
Prasad, JVNV
Para, KS
Tummino, PJ
Ferguson, D
Lunney, EA
Blankley, CJ
机构
[1] Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor
关键词
D O I
10.1016/0960-894X(96)00180-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In a study of 4-hydroxy-pyran-2-ones as possible inhibitors of HIV protease, a series of compounds were synthesized following the Topliss operational scheme for substitution on a phenyl group at the 6 position of the pyrone. In addition, a number of compounds with polar substituents were made. (C) 1996 Elsevier Science Ltd
引用
收藏
页码:1099 / 1104
页数:6
相关论文
共 10 条
[1]   INHIBITORS OF HIV-1 PROTEASE [J].
MEEK, TD .
JOURNAL OF ENZYME INHIBITION, 1992, 6 (01) :65-98
[2]   A SIMPLE PROCEDURE FOR THE SYNTHESIS OF 3-(SUBSTITUTED-SULFANYL)-4-HYDROXY-6-SUBSTITUTED-PYRAN-2-ONES [J].
PARA, KS ;
ELLSWORTH, EL ;
PRASAD, JVN .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1994, 31 (06) :1619-1624
[3]   HIV PROTEASE INHIBITORS POSSESSING A NOVEL, HIGH-AFFINITY, AND ACHIRAL P-1'/P-2' LIGAND WITH A UNIQUE PATTERN OF IN-VITRO RESISTANCE - IMPORTANCE OF A CONFORMATIONALLY-RESTRICTED TEMPLATE IN THE DESIGN OF ENZYME-INHIBITORS [J].
PRASAD, JVNV ;
LUNNEY, EA ;
FERGUSON, D ;
TUMMINO, PJ ;
RUBIN, JR ;
REYNER, EL ;
STEWART, BH ;
GUTTENDORF, RJ ;
DOMAGALA, JM ;
SUVOROV, LI ;
GULNIK, SV ;
TOPOL, IA ;
BHAT, TN ;
ERICKSON, JW .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1995, 117 (45) :11070-11074
[4]  
PRASAD JVNV, 1994, J AM CHEM SOC, V116, P6989
[5]  
REDSHAW S, 1994, EXPERT OPIN INV DRUG, V3, P273
[6]   RATIONAL DESIGN OF PEPTIDE-BASED HIV PROTEINASE-INHIBITORS [J].
ROBERTS, NA ;
MARTIN, JA ;
KINCHINGTON, D ;
BROADHURST, AV ;
CRAIG, JC ;
DUNCAN, IB ;
GALPIN, SA ;
HANDA, BK ;
KAY, J ;
KROHN, A ;
LAMBERT, RW ;
MERRETT, JH ;
MILLS, JS ;
PARKES, KEB ;
REDSHAW, S ;
RITCHIE, AJ ;
TAYLOR, DL ;
THOMAS, GJ ;
MACHIN, PJ .
SCIENCE, 1990, 248 (4953) :358-361
[7]   Structure-based design of sulfonamide-substituted non-peptidic HIV protease inhibitors [J].
Skulnick, HI ;
Johnson, PD ;
Howe, WJ ;
Tomich, PK ;
Chong, KT ;
Watenpaugh, KD ;
Janakiraman, MN ;
Dolak, LA ;
McGrath, JP ;
Lynn, JC ;
Horng, MM ;
Hinshaw, RR ;
Zipp, GL ;
Ruwart, MJ ;
Schwende, FJ ;
Zhong, WZ ;
Padbury, GE ;
Dalga, RJ ;
Shiou, LH ;
Possert, PL ;
Rush, BD ;
Wilkinson, KF ;
Howard, GM ;
Toth, LN ;
Williams, MG ;
Kakuk, TJ ;
Cole, SL ;
Zaya, RM ;
Lovasz, KD ;
Morris, JK ;
Romines, KR ;
Thaisrivongs, S ;
Aristoff, PA .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (26) :4968-4971
[8]   UTILIZATION OF OPERATIONAL SCHEMES FOR ANALOG SYNTHESIS IN DRUG DESIGN [J].
TOPLISS, JG .
JOURNAL OF MEDICINAL CHEMISTRY, 1972, 15 (10) :1006-&
[9]  
Topliss JG, 1975, DRUG DESIGN, VV, P1
[10]   COMPETITIVE-INHIBITION OF HIV-1 PROTEASE BY 4-HYDROXY-BENZOPYRAN-2-ONES AND BY 4-HYDROXY-6-PHENYLPYRAN-2-ONES [J].
TUMMINO, PJ ;
FERGUSON, D ;
HUPE, L ;
HUPE, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (03) :1658-1664